Downgrading

From The Jolly Contrarian
Revision as of 11:44, 30 October 2019 by Amwelladmin (talk | contribs)
Jump to navigation Jump to search
Negotiation Anatomy™

Eye-ess-dee-aye, yesterday.
Tell me more
Sign up for our newsletter — or just get in touch: for ½ a weekly 🍺 you get to consult JC. Ask about it here.

Downgrading personnel is the process of finding a cheaper unit to do the same job.

Once upon a time

When the JC was but a stripling clerk, his senior partner assigned to him the job of reviewing this speculative new contract for an important finance client. This was in about 1995.

“The client will take potentially massive, long-tenor exposures under this new contract,” said he, knocking his pipe out on my head. “Potentially ruinous ones. It is our sacred duty to make sure it is safe! And that means —”

The partner’s eyes glittered.

“Daily mark-to-market variation margin?” I offered.[1]

“No, boy, no!” he shrieked. “No, no, no!”

For a moment I was flummoxed, but then I saw in those black eyes the fierce gleam that comes from countenancing vast professional fees, and I understood.

“Billings!”

He held out his hand. In his palm: a red pill and a blue pill.

I regarded the document, and then the pills. The contract was slim, rendered on crisp onionskin. It had a five-part Schedule at the back. It was beautiful — ineffable — alien in its obliqueness. I mouthed its title, printed in block capitals across the front page: “Eye-ess-dee-aye”.

Exactly! said he. “A sw-æp agreement!”

I flipped the pages. My mind whirred with the other-worldly concepts I beheld: Single Agreement. Merger Without Assumption. Netting. Gross-Up. Default Under Specified Transaction. What could they all mean? I didn't know. I didn’t understand. But I knew — I felt it, deep in my fibre. I needed to know.

I took the red pill.

And, ladies and gentlemen, that is how we find ourselves looking at each other today, through the vale of tears and resentment we both know as a liquid crystal display. Yes: it is a matrix, and I am stuck in here. But, look: don’t worry about me: I can't bear mawkish sentimentality. I wouldn’t feel sorry for you if the roles were reversed. And, after all, I shall outlive you all.

What does this all mean?

Ok: enough of the cod-philosophical sci-fi. The notional amount of OTC derivatives traded in 1995[2], when I took my red pill, was roughly USD12 trillion. By 2018 it was nudging USD600 trillion[3]. Six hundred trillion bucks.[4]

In any case, an ISDA Master Agreement was once a rare and special beast. Nowadays it isn’t — financial institutions negotiate thousands of them every year — and, for fifteen or twenty years management consultants all over the globe have pored over the costs of negotiation to see how to bring them down. This means some kind of triage. The partner flipped it to the associate, to the trainee, to the in-house lawyer, to the ISDA negotiator, to the operations clerk.

It has led to the great dogma of contract negotiation: “Percy! Find me people cheaper units to negotiate these contracts!”

First they came for the antipodeans. Then for school leavers in former satellite states of the Soviet Union. Then for people Northern Ireland. Then Bristol. Now they are scouring the outer suburbs of Birmingham.

But throughout it all the ISDA Master Agreement, with its different editions and their insufferable tax representations, its schedule, annexes, protocols, definitions booklets, every word of which rendered in a committee-crafted prose of the 19th century, remained the same. Never once did anyone ask: do we really need all of this? Is it really feasible to expect school-leavers from Bratislava to wade through all this?

See also

References

  1. Yes, of course this is an outrageous lie: I was an ISDA ingénue; I had not the first clue about derivatives, and certainly nothing so sophisticated as credit support, if it even existed at the time.
  2. According to BIS Triennial Review, since you are asking. Let me Google that for you.
  3. According to ISDA.
  4. I know, I know: that is gross notional and not net outstanding exposure. But still.